Revium Rx (RVRC) Interest Expenses (2024 - 2025)
Revium Rx (RVRC) posted Interest Expenses of $2.1 million for Q4 2025, up 67.09% sequentially from $1.3 million in Q4 2024, and up 67.09% YoY from $1.3 million in Q4 2024.
Revium Rx (RVRC) Interest Expenses (2024 - 2025) Analysis & Trends
Revium Rx has reported Interest Expenses for 2 years, with the latest figure at $2.1 million in Q4 2025.
- Quarterly Interest Expenses rose 67.09% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 67.09% YoY) and the FY2025 annual result came in at $10.7 million, up 717.57% from the prior year.
- Interest Expenses climbed to $2.1 million in Q4 2025 per RVRC's latest filing, from $1.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $2.1 million in Q4 2025 and troughed at $1.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 291.00 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 58.49 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 25.00 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 95.04 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 71.31 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 11.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 19.65 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 157.52 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 184.11 Mn |
| 10 | Revium Rx | 101.42 Mn | 99.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2024 | 1.25 Mn |